Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study
Fecha de publicación
2015Título de revista
Journal Of Clinical Oncology
Tipo de contenido
Publicación de congreso